about
Nonsteroidal antiinflammatory drugs after acute myocardial infarctionAdverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.Validity of the GRACE (Global Registry of Acute Coronary Events) acute coronary syndrome prediction model for six month post-discharge death in an independent data set.Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysisComparative-effectiveness of revascularization versus routine medical therapy for stable ischemic heart disease: a population-based studyHospital volume and 30-day mortality for three common medical conditionsTechniques for estimating health care costs with censored data: an overview for the health services researcherAssociation between appropriateness of coronary revascularization and quality of life in patients with stable ischemic heart disease.Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.Determinants of cardiac catheterization use in older Medicare patients with acute myocardial infarction.Risks associated with statin therapy: a systematic overview of randomized clinical trials.A population-based study of the drug interaction between proton pump inhibitors and clopidogrelPredicting EQ-5D utility scores from the Seattle Angina Questionnaire in coronary artery disease: a mapping algorithm using a Bayesian framework.Drug eluting balloons for de novo coronary lesions - a systematic review and meta-analysisSocioeconomic status, functional recovery, and long-term mortality among patients surviving acute myocardial infarction.The impact of cardiovascular disease prevalence on women's enrollment in landmark randomized cardiovascular trials: a systematic review.Determinants of variations in coronary revascularization practices.Use of fibrates in the United States and CanadaAssociation of hospital spending intensity with mortality and readmission rates in Ontario hospitalsThe average lifespan of patients discharged from hospital with heart failureAppropriateness of spironolactone prescribing in heart failure patients: a population-based study."Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes.The use of a cytokine panel to define the long-term risk stratification of heart failure/death in patients presenting with chest pain to the emergency department.Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population.Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification?Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarctionIndicators of quality of care for patients with acute myocardial infarction.Ecological studies and cardiovascular outcomes research.Rates and risk factors for prolonged opioid use after major surgery: population based cohort study.PAPP-A as a marker of increased long-term risk in patients with chest pain.Percutaneous coronary intervention with vs without on-site cardiac surgery backup: a systematic review and meta-analysis.Reporting and representation of ethnic minorities in cardiovascular trials: a systematic review.Rate and predictors of the conversion of abstracts presented at the Canadian Cardiovascular Congress scientific meetings to full peer-reviewed publications.Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial.Long-term health outcomes associated with detectable troponin I concentrations.Factors explaining the under-use of reperfusion therapy among ideal patients with ST-segment elevation myocardial infarction.Can coronary calcification measured by CT predict future coronary events?Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years.
P50
Q28192441-19C465D9-33B9-47CA-A906-4EC551AEE0C8Q31132556-D7900706-F3E6-4148-8ADE-F061DD425EE4Q33230635-BB71B4E8-3182-4D38-957C-89C09DAE9C29Q33445307-11125C18-12CC-4DD4-9FDF-A4889032D5F8Q33770249-434F28F5-EB51-474F-BEC4-5E8E0E63F26AQ33893065-87019FB9-FA48-4C3F-8DB0-EC98228138CAQ34311479-4DC76C2E-4CE0-4A4F-ABBE-CC22097506DEQ34333147-525D9BC6-4CDB-4C67-9735-E02F0A7ED771Q34385649-B572F7D3-7EC0-43F1-B273-157931F0A189Q34506171-5447D6E2-33B3-4B7A-8D41-29D1AC1B806DQ34589564-9632EE30-0E2C-46D1-ABA7-DC7CFCF73FB1Q34603772-7AC8CCED-50E2-4AD5-ACE7-4CDBE87EE372Q34625565-46918677-9B45-41EC-A4D6-BF05AB14DBB9Q34711426-5575BCC0-238A-4F7C-83E7-DE8807C89B5CQ34766102-FAA3BE65-0A0A-43D8-9ECF-CF1328B8AA7BQ35648963-35EE03E7-8AFE-41CB-A52C-165A86BC1281Q35739868-6145733C-2A4A-486B-A2BB-911FDBC23596Q35903762-2A84DBFB-212C-441A-B60B-665460CB5861Q35920118-F26FA53A-E057-4289-8EC9-C32ADCA567E5Q36447299-25BF8835-9D04-4140-9877-30D86DE1FCC2Q36453684-F9102E5C-7254-42C3-B90E-F4E842F1DFA8Q36601665-3A063A98-784F-4E74-8F6F-424828644820Q36601675-E149D236-74E5-4419-A61C-87ECF69B159BQ36601689-D438A00A-3B3F-4656-A0D7-2306B64E4F0EQ36601693-9C7C8C49-1A45-4565-8EE1-560562702B5CQ36601701-85D8ECED-C5C4-46E5-A224-18AF1AD672A8Q36932631-F8F610A7-CDA0-485F-BE14-424590938897Q36932645-B191CD91-69A6-4E7B-9E59-2583A152D1E8Q36932653-306FE786-D42D-4442-AFFB-807761C24A87Q37344088-BA2221C3-E401-4D85-8673-8A8493BDABECQ37578487-71890CEE-D01B-4FB3-A4DE-0198775908B9Q37696962-B1B7D740-FC5D-40B0-9E8C-059E18D99F5EQ37872462-69B22B31-8365-4858-BCE6-44C7A5A0B738Q38118421-E5BE502F-D928-43F6-8198-D29EA410DB83Q38158564-DE7C800B-E6D9-4936-ACC1-4F2CFEF97650Q38377589-3161BC79-067A-4BF9-BA70-65D0776DEB5AQ40254348-C6C0ACAA-8462-4DD6-B339-4CACC37F718EQ40318237-3F9C15EF-CB07-45A1-8A60-45A0693D3553Q40378330-209BFF50-7B1A-4314-B08C-834BD404F512Q43120645-F2A1CED1-68F3-4CB7-BBB9-6001509A775D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dennis Ko
@ast
Dennis Ko
@en
Dennis Ko
@es
Dennis Ko
@nl
Dennis Ko
@sl
Денис Гао
@ru
دينيس كو
@ar
type
label
Dennis Ko
@ast
Dennis Ko
@en
Dennis Ko
@es
Dennis Ko
@nl
Dennis Ko
@sl
Денис Гао
@ru
دينيس كو
@ar
prefLabel
Dennis Ko
@ast
Dennis Ko
@en
Dennis Ko
@es
Dennis Ko
@nl
Dennis Ko
@sl
Денис Гао
@ru
دينيس كو
@ar
P106
P1153
7103246001
P21
P31
P496
0000-0001-6840-8051